Literature DB >> 34458960

SGLT2 Inhibitors: The Dawn of a New Era in Cardio-Metabolic Therapeutics.

Prakash Deedwania1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34458960     DOI： 10.1007/s40256-021-00495-5

Source DB:  PubMed          Journal:  Am J Cardiovasc Drugs        ISSN： 1175-3277            Impact factor:   3.571


× No keyword cloud information.
  2 in total

1.  Comparative Efficacy of Five SGLT2i on Cardiorenal Events: A Network Meta-analysis Based on Ten CVOTs.

Authors:  Mei Qiu; Liang-Liang Ding; Hai-Rong Zhou
Journal:  Am J Cardiovasc Drugs       Date:  2021-07-07       Impact factor: 3.571

Review 2.  Current and Emerging Classes of Pharmacological Agents for the Management of Hypertension.

Authors:  Utkarsh Ojha; Sanjay Ruddaraju; Navukkarasu Sabapathy; Varun Ravindran; Pitchaya Worapongsatitaya; Jeesanul Haq; Raihan Mohammed; Vinod Patel
Journal:  Am J Cardiovasc Drugs       Date:  2021-12-08       Impact factor: 3.283
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.